Reoperations after surgery for acute subdural hematoma: reasons, risk factors, and effects.


Journal

European journal of trauma and emergency surgery : official publication of the European Trauma Society
ISSN: 1863-9941
Titre abrégé: Eur J Trauma Emerg Surg
Pays: Germany
ID NLM: 101313350

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 18 08 2018
accepted: 18 01 2019
pubmed: 24 1 2019
medline: 4 2 2021
entrez: 24 1 2019
Statut: ppublish

Résumé

To analyze the reasons and patient-related and injury-related risk factors for reoperation after surgery for acute subdural hematoma (SDH) and the effects of reoperation on treatment outcome. Among adult patients operated on for acute SDH between 2013 and 2017, patients reoperated within 14 days after the primary surgery were identified. In all patients, parameters were identified that related to the patient (age, anticoagulation, antiplatelet, and antiepileptic treatment, and alcohol intoxication), trauma (Glasgow Coma Score, SDH thickness, midline shift, midline shift /hematoma thickness rate, other surgical lesion, primary surgery-trephination, craniotomy, or decompressive craniotomy), and Glasgow Outcome Score (GOS). The reasons for reoperation and intervals between primary surgery and reoperation were studied. Of 86 investigated patients, 24 patients were reoperated (27.9%), with a median interval of 2 days between primary surgery and reoperation. No significant differences in patients and injury-related factors were found between reoperated and non-reoperated patients. The rate of primary craniectomies was higher in non-reoperated patients (P = 0.066). The main indications for reoperation were recurrent /significant residual SDH (10 patients), contralateral SDH (5 patients), and expansive intracerebral hematoma or contusion (5 patients). The final median GOS was 3 in non-reoperated and 1.5 in reoperated patients, with good outcomes in 41.2% of non-reoperated and 16.7% of reoperated patients. Reoperation after acute SDH surgery is associated with a significantly worse prognosis. Recurrent /significant residual SDH and contralateral SDH are the most frequently found reasons for reoperation. None of the analyzed parameters were significant reoperation predictors.

Identifiants

pubmed: 30671588
doi: 10.1007/s00068-019-01077-6
pii: 10.1007/s00068-019-01077-6
doi:

Substances chimiques

Anticoagulants 0
Anticonvulsants 0
Platelet Aggregation Inhibitors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

347-355

Références

Korean J Neurotrauma. 2018 Apr;14(1):14-19
pubmed: 29774193
J Trauma. 2011 Dec;71(6):1632-6
pubmed: 22027888
World Neurosurg. 2017 Sep;105:749-754
pubmed: 28645605
Neurol Med Chir (Tokyo). 2013;53(4):221-4
pubmed: 23615411
J Neurol Surg A Cent Eur Neurosurg. 2017 Nov;78(6):535-540
pubmed: 28249306
No Shinkei Geka. 2004 Mar;32(3):271-6
pubmed: 15148802
Br J Neurosurg. 2017 Feb;31(1):78-83
pubmed: 27596026
J Neurosurg. 2011 Jan;114(1):47-52
pubmed: 20722610
World Neurosurg. 2016 Apr;88:569-575
pubmed: 26523763
J Trauma. 2010 Jan;68(1):E11-2
pubmed: 19065118
Exp Ther Med. 2015 Jul;10(1):225-230
pubmed: 26170939
Cureus. 2016 May 20;8(5):e616
pubmed: 27382524
Br J Neurosurg. 2000 Apr;14(2):110-6
pubmed: 10889882
J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1275-9
pubmed: 20643657
Acta Chir Orthop Traumatol Cech. 2014;81(1):77-84
pubmed: 24755061
J Korean Neurosurg Soc. 2017 Nov;60(6):723-729
pubmed: 29142633
World Neurosurg. 2018 Dec;120:e1024-e1030
pubmed: 30201582
Neurosurg Rev. 2018 Apr;41(2):483-488
pubmed: 28685310
Eur J Trauma Emerg Surg. 2013 Jun;39(3):277-83
pubmed: 26815234
J Neurosurg. 2002 Jan;96(1):109-16
pubmed: 11794591
World Neurosurg. 2017 May;101:335-342
pubmed: 28216211
Korean J Neurotrauma. 2016 Oct;12(2):61-66
pubmed: 27857909
J Clin Neurosci. 2013 Apr;20(4):509-13
pubmed: 23403173
Surg Neurol. 2003 Jul;60(1):23-30; discussion 30
pubmed: 12865006
BMC Surg. 2015 Oct 14;15:111
pubmed: 26467905
J Neurosurg. 2015 Oct;123(4):1065-9
pubmed: 25909568
Neurosurg Clin N Am. 2017 Apr;28(2):267-278
pubmed: 28325461
Neurosurgery. 1994 Dec;35(6):1061-4; discussion 1064-5
pubmed: 7885549
J Trauma. 2008 Dec;65(6):1298-302
pubmed: 19077617
BMC Neurol. 2015 Oct 24;15:220
pubmed: 26496765

Auteurs

Jan Chrastina (J)

Department of Neurosurgery, Faculty of Medicine, St. Anne's Hospital Brno, Masaryk University, Pekařská 53, 656 91, Brno, Czech Republic. jan.chrastina@fnusa.cz.

Čeněk Šilar (Č)

Department of Neurosurgery, Faculty of Medicine, St. Anne's Hospital Brno, Masaryk University, Pekařská 53, 656 91, Brno, Czech Republic.

Tomáš Zeman (T)

Department of Neurosurgery, Faculty of Medicine, St. Anne's Hospital Brno, Masaryk University, Pekařská 53, 656 91, Brno, Czech Republic.

Michal Svoboda (M)

Institute of Biostatistics and Analyses, Masaryk University Medical Faculty, Brno, Czech Republic.

Jan Krajsa (J)

Faculty of Medicine, Institute of Forensic Medicine, Masaryk University, Brno, Czech Republic.

Barbora Musilová (B)

Department of Neurosurgery, Faculty of Medicine, St. Anne's Hospital Brno, Masaryk University, Pekařská 53, 656 91, Brno, Czech Republic.

Zdeněk Novák (Z)

Department of Neurosurgery, Faculty of Medicine, St. Anne's Hospital Brno, Masaryk University, Pekařská 53, 656 91, Brno, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH